Not finding it? Sign in to also search OpenAlex live.
-
Internet-based problem solving therapy improves depressive and dialysis related physical symptoms in hemodialysis patients under 65 years of age: A post-hoc secondary subgroup analysis of a cluster randomized controlled trial
Debbie Zittema, Robbert W. Schouten, Els Nadort, Rosa E. Boeschoten, Yves F.C. Smets, Prataap Chandie Shaw, +11 more
0citations -
PROTECT Subgroup Analysis: Clinical Benefits of Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with IgAN Who Have Proteinuria above and below 1 g/g2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Laura Ann Kooienga, Hernán Trimarchi, Jürgen Floege, Priscila Preciado, Jai Radhakrishnan
0citations -
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status2021 Clinical Epigenetics article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philipp Sebastian Jurmeister, Karsten Ernst Weber, Sonia Lorena Villegas, Thomas Karn, Michael Untch, Anne Thieme, +14 more
5citations -
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial
Mark Andrew Espeland, Richard E. Pratley, Julio Rosenstock, Takashi Kadowaki, Yutaka Seino, Bernard Zinman, +7 more
33citations -
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid2022 Headache The Journal of Head and Face Pain article Medicine Migraine and Headache Studies Open access
Michel D. Ferrari, Karin W.M. Zuurbier, Steve Barash, Xiaoping Ning, Joshua M. Cohen
11citations -
#3345 Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Richard A. Lafayette, Heather N. Reich, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, +4 more
0citations -
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
Antoinette MaassenVanDenBrink, Gisela Marie Terwindt, Joshua M. Cohen, Steve Barash, Verena Ramirez Campos, Maja Galić, +2 more
19citations -
The clinical effectiveness of a self-management intervention for patients with persistent depressive disorder and their partners/caregivers: results from a multicenter, pragmatic randomized controlled trial
Ericka C. Solis, Ingrid V. E. Carlier, Noëlle G. A. Kamminga, Erik J. Giltay, Albert M. van Hemert
3citations -
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES2022 Canadian Journal of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Chern‐En Chiang, Gregory G. Schwartz, Yedid Elbez, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, +11 more
14citations -
LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial
Jane A. O’Halloran, Kevin Joseph Anstrom, Eyal Kedar, Matthew William McCarthy, Emily R. Ko, Richard Melsheimer, +4 more
0citations